Patient info

Paracetamol 120 mg/5 ml – patient leaflet, side effects, dosage

Updated:
Medicine strength:
120 mg / 5 ml
Contains active substance:

Patient leaflet - Paracetamol 120 mg / 5 ml oral suspension

1. WHAT PARACETAMOL ORAL SUSPENSION IS AND WHAT IT IS USED FOR

Paracetamol 120 mg/5 ml Oral Suspension (“Paracetamol Oral Suspension”) contains paracetamol to relieve pain and reduce high temperatures. Paracetamol Oral Suspension can be used in babies and children for the treatment of pain and feverishness associated with teething, toothache, headache, colds and flu. It can also be used in babies who develop fever after vaccination.

2. WHAT YOU NEED TO KNOW BEFORE YOU USE PARACETAMOL ORAL SUSPENSION

DO NOT give Paracetamol Oral Suspension if your child is taking any other paracetamol-containing products, other flu, cold, cough or decongestant products.

DO NOT give Paracetamol Oral Suspension to your child if he/she:

  • is allergic (hypersensitive) to paracetamol, or any of the other ingredients of Paracetamol Oral Suspension (see Section 6 and end of Section 2).
  • has kidney or liver problems

If you are not sure about any of the above, please consult your doctor.

Warnings and precautions

If your child does not get better, talk to your doctor.

During treatment with Paracetamol, tell your doctor straight away:

If you have severe illnesses, including severe renal impairment or sepsis (when bacteria and their toxins circulate in the blood leading to organ damage), or you suffer from malnutrition, chronic alcoholism or if you are also taking flucloxacillin (an antibiotic). A serious condition called metabolic acidosis (a blood and fluid abnormality) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken together with flucloxacillin. Symptoms of metabolic acidosis may include: serious breathing difficulties with deep rapid breathing, drowsiness, feeling sick (nausea) and being sick (vomiting). Other medicines and Paracetamol Oral Suspension

Tell your doctor or pharmacist if your child is taking, or has recently taken, any other medicine, even those obtained without a prescription, but especially medicines which:

  • are to treat ‘flu’ or a cold, containing paracetamol and/or a decongestant
  • thin the blood (e.g. warfarin)
  • control nausea and vomiting (e.g. domperidone or metoclopramide)
  • reduce levels of cholesterol and other fats in the blood (e.g. cholestyramine)
  • treat epilepsy (e.g. anti-convulsants)
  • have been prescribed by your doctor to improve sleep (e.g. barbiturates), or for anxiety or depression (e.g. tricyclic antidepressants).
  • contain flucloxacillin (antibiotic), due to a serious risk of blood and fluid abnormality (called metabolic acidosis) that must have urgent treatment (see section 2).

The effects of alcohol may be increased whilst taking Paracetamol Oral Suspension.

Avoid alcohol while taking this medicine.

Pregnancy and breast-feeding

This medicine is intended for use in children.

If necessary, Paracetamol Oral Suspension can be used during pregnancy. Ask your doctor or pharmacist for advice before taking any medicines during pregnancy or breast-feeding. You should use the lowest possible dose that reduces your pain and/or your fever and use it for the shortest time possible. Contact your doctor if the pain and/or fever are not reduced or if you need to take the medicine more often. Driving and using machines

This medicine is intended for use in children. However, it should be noted that Paracetamol Oral Suspension is not expected to affect ability to drive or operate machinery.

Important information about some of the ingredients of Paracetamol Oral Suspension

Paracetamol Suspension contains:

  • Ethanol: This medicinal product contains small quantities of ethanol (alcohol), less than 100 mg per 5 ml. (It contains up to 0.08 g of ethanol (alcohol) per 5 ml dose, equivalent to less than 2 ml beer or 1 ml wine per 5 ml dose).
  • Liquid Maltitol Syrup (E965): if your child has an intolerance to some sugars including fructose, contact your doctor before giving this medicine.

3. HOW TO USE PARACETAMOL ORAL SUSPENSION

Check the tables overleaf to see how much of the medicine to use

  • For oral use only
  • Never give more medicine than shown in the table
  • Do not overfill the spoon
  • Always use the spoon supplied with the pack
  • Do not give anything else containing paracetamol while giving this medicine
Helvetica 10pt - 9pt
297 x 210mm

***

*** *** ***

***

Version: 1

Other information: Previous code - 23LF02107PW

PRAC updates

23LF02151PW

FRONT PAGE (pg1/2) Children aged 3 months - 6 years:

For the relief of fever after vaccination at 2, 3 and 4 months

2.5 ml. This dose may be given up to 4 times a day at the time of vaccination. Do not give more than 4 doses in any 24 hour period. Leave at least 4 hours between doses. If your baby still needs this medicine two days after receiving the vaccine talk to your doctor or pharmacist.

If your child takes more of this medicine than they should:

Talk to a doctor at once if your child takes too much of this medicine even if they seem well. This is because too much paracetamol can cause delayed, serious liver damage.

If you forget to give this medicine:

If you miss a dose give it as soon as you remember and take any remaining doses for that day at evenly spaced times. Do not take a double dose to make up for the missed dose.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Paracetamol Oral Suspension can cause side effects although not everybody gets them. You or your child may notice the following:

  • rash, itchy skin, swelling of the lips, eyes, tongue, or difficulty in breathing, which may be signs of an allergic reaction. STOP giving Paracetamol Oral Suspension to your child immediately.
  • blood disorders

Very rare cases of serious skin reactions have been reported.

Frequency “Not known’’ (frequency cannot be estimated from the available data): “A serious condition that can make blood more acidic (called metabolic acidosis), in patients with severe illness using paracetamol (see section 2)”.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE PARACETAMOL ORAL SUSPENSION Keep this medicine out of the sight and reach of children.

Do not store above 25˚C. Store in the original container. Keep the container in the outer carton. Do not use this medicine after the expiry date which is stated on the label and/or carton. The expiry date refers to the last day of that month.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Paracetamol Oral Suspension contains

Each 5 ml of Paracetamol Oral Suspension contains:

  • The active ingredient: paracetamol 120 mg.
  • The other ingredients are: ethanol, sorbitan monooleate, glycerol (E422), magnesium aluminium silicate, liquid maltitol syrup (E965), saccharin sodium (E954), xanthan gum, cherry flavour, sodium benzoate (E211), citric acid monohydrate, polysorbate 80 and purified water (see end of Section 2 for further information).

What Paracetamol Oral Suspension looks like and contents of the pack:

Paracetamol Oral Suspension is a cream to brown oral suspension with cherry odour and taste presented in 70 ml, 100 ml, 150 ml and 200 ml amber glass bottles with pilfer-proof screw caps. A 2.5 ml/5 ml measuring spoon is provided. This medicinal product is a colour free and sugar free product.

Marketing Authorisation Holder:

Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland.

Product Licence Number: PL 04917/0028

Manufacturers:

Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland or

CP Pharmaceuticals Ltd., Ash Road North, Wrexham, LL13 9UF.

Date of revision: January 2025

Helvetica 10pt - 9pt
297 x 210mm

***

*** *** ***

***

Version: 1

Other information: Previous code - 23LF02107PW

PRAC updates

Child’s AgeHow MuchHow often (in 24 hours)
3 - 6 months2.5 ml4 times
6 - 24 months5 ml4 times
2 - 4 years7.5 ml (5 ml + 2.5 ml)4 times
4 - 6 years10 ml (5 ml + 5 ml)4 times
  • Do not give more than 4 doses in any 24-hour period
  • Leave at least 4 hours between doses
  • Do not give this medicine to your child for more than 3 days without speaking to your doctor or pharmacist It is important to shake the bottle for at least 10 seconds before use.

23LF02151PW

BACK PAGE (pg2/2)

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04917/0028

Last revision stated in the text: January 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Paracetamol 120 mg / 5 ml oral suspension

Active substance Paracetamol
Strength 120 mg / 5 ml
Pharmaceutical form Cream to brown oral suspension with cherry odour and taste.
Excipients Ethanol 96%, Sorbitan Monooleate, Glycerol (E422), Magnesium Aluminium Silicate, Liquid Maltitol (E965), Saccharin Sodium (E954), Xanthan Gum, Cherry Flavour, Sodium Benzoate (E211), Citric Acid (monohydrate), Polysorbate 80, Purified water
Shelf life Amber glass bottles – 5 years
High density polyethylene – 5 years.
Storage Do not store above 25°C. Store in the original container. Keep container in the outer carton.
Drug group (ATC) Non-Opioid Analgesic, Antipyretics (Anilides)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02B Other analgesics and antipyretics
        1. N02BE Anilide analgesics and antipyretics
          1. N02BE01 paracetamol
Marketing authorisation PL 04917/0028 (first authorised 23 March 2007), PL 20416/0521 (first authorised 22 November 2024)
Marketing authorisation holder Pinewood Laboratories Limited, Crescent Pharma Limited

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.